DRG 251

Surgical DRG

Percutaneous Cardiovascular Procedures without Intraluminal Device without MCC

TypeSurgicalMDC05

What is MS-DRG 251?

MS-DRG 251 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) without a significant Complication or Comorbidity. For FY 2026 it carries a relative weight of 1.4945 with a geometric mean length of stay of 2 days and an arithmetic mean of 2.4 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Surgical DRG
Procedure-driven grouping
Linked Codes
0 diagnosis
35 procedure

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
1.4945
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
2 days
Used for transfer payment calculations
Arithmetic Mean LOS
2.4 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
250Percutaneous Cardiovascular Procedures without Intraluminal Device with MCC2.18253.1 days
251Percutaneous Cardiovascular Procedures without Intraluminal Device without MCCThis page1.49452 days

Linked ICD-10-PCS Procedure Mappings

  • 02570ZK

    Destruction of Left Atrial Appendage, Open Approach

    BillableSection 0
  • 02700ZZ

    Dilation of Coronary Artery, One Artery, Open Approach

    BillableSection 0
  • 02710ZZ

    Dilation of Coronary Artery, Two Arteries, Open Approach

    BillableSection 0
  • 02720ZZ

    Dilation of Coronary Artery, Three Arteries, Open Approach

    BillableSection 0
  • 02730ZZ

    Dilation of Coronary Artery, Four or More Arteries, Open Approach

    BillableSection 0
  • 02B70ZK

    Excision of Left Atrial Appendage, Open Approach

    BillableSection 0
  • 02FP3Z0

    Fragmentation of Pulmonary Trunk, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FP3ZZ

    Fragmentation of Pulmonary Trunk, Percutaneous Approach

    BillableSection 0
  • 02FQ3Z0

    Fragmentation of Right Pulmonary Artery, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FQ3ZZ

    Fragmentation of Right Pulmonary Artery, Percutaneous Approach

    BillableSection 0
  • 02FR3Z0

    Fragmentation of Left Pulmonary Artery, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FR3ZZ

    Fragmentation of Left Pulmonary Artery, Percutaneous Approach

    BillableSection 0
  • 02FS3Z0

    Fragmentation of Right Pulmonary Vein, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FS3ZZ

    Fragmentation of Right Pulmonary Vein, Percutaneous Approach

    BillableSection 0
  • 02FT3Z0

    Fragmentation of Left Pulmonary Vein, Percutaneous Approach, Ultrasonic

    BillableSection 0
  • 02FT3ZZ

    Fragmentation of Left Pulmonary Vein, Percutaneous Approach

    BillableSection 0
  • 02U037Z

    Supplement Coronary Artery, One Artery with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U038Z

    Supplement Coronary Artery, One Artery with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U03JZ

    Supplement Coronary Artery, One Artery with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U03KZ

    Supplement Coronary Artery, One Artery with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U137Z

    Supplement Coronary Artery, Two Arteries with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U138Z

    Supplement Coronary Artery, Two Arteries with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U13JZ

    Supplement Coronary Artery, Two Arteries with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U13KZ

    Supplement Coronary Artery, Two Arteries with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U237Z

    Supplement Coronary Artery, Three Arteries with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U238Z

    Supplement Coronary Artery, Three Arteries with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U23JZ

    Supplement Coronary Artery, Three Arteries with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U23KZ

    Supplement Coronary Artery, Three Arteries with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U337Z

    Supplement Coronary Artery, Four or More Arteries with Autologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U338Z

    Supplement Coronary Artery, Four or More Arteries with Zooplastic Tissue, Percutaneous Approach

    BillableSection 0
  • 02U33JZ

    Supplement Coronary Artery, Four or More Arteries with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U33KZ

    Supplement Coronary Artery, Four or More Arteries with Nonautologous Tissue Substitute, Percutaneous Approach

    BillableSection 0
  • 02U73JZ

    Supplement Left Atrium with Synthetic Substitute, Percutaneous Approach

    BillableSection 0
  • 02U74JZ

    Supplement Left Atrium with Synthetic Substitute, Percutaneous Endoscopic Approach

    BillableSection 0
  • X2A7358

    Intermittent Coronary Sinus Occlusion, Percutaneous Approach, New Technology Group 8

    BillableSection X